The increasing prevalence of arboviral diseases poses significant health risks, especially in regions with limited healthcare infrastructure. Severe cases of diseases like yellow fever can lead to fatalities if not managed promptly. Vulnerable populations, including those in remote areas, are at higher risk due to inadequate access to critical care services. The guidelines aim to mitigate these risks by standardising clinical practices and improving patient outcomes. However, their effectiveness depends on the adoption and implementation by healthcare providers and policymakers.